223 related articles for article (PubMed ID: 2413147)
1. Geographic variation among isolates of Trichomonas vaginalis: demonstration of antigenic heterogeneity by using monoclonal antibodies and the indirect immunofluorescence technique.
Krieger JN; Holmes KK; Spence MR; Rein MF; McCormack WM; Tam MR
J Infect Dis; 1985 Nov; 152(5):979-84. PubMed ID: 2413147
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic variation of surface antigenic determinants in Trichomonas vaginalis detected by monoclonal antibodies.
Fíori PL; Rappelli P; Manca C; Mattana A; Cappuccinelli P
Microbiologica; 1992 Jul; 15(3):227-35. PubMed ID: 1380113
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody to a major surface glycoprotein immunogen differentiates isolates and subpopulations of Trichomonas vaginalis.
Alderete JF; Suprun-Brown L; Kasmala L
Infect Immun; 1986 Apr; 52(1):70-5. PubMed ID: 3514466
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against Trichomonas vaginalis.
Chang TH; Tsing SY; Tzeng S
Hybridoma; 1986; 5(1):43-51. PubMed ID: 3514432
[TBL] [Abstract][Full Text] [Related]
5. Antigenic heterogeneity in the 115,000 Mr major surface antigen of Trichomonas vaginalis.
Torian BE; Connelly RJ; Barnes RC; Kenny GE
J Protozool; 1988 May; 35(2):273-80. PubMed ID: 2456385
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of Trichomonas vaginalis and discrimination among trichomonal isolates and subpopulations with sera of patients and experimentally infected mice.
Alderete JF; Suprun-Brown L; Kasmala L; Smith J; Spence M
Infect Immun; 1985 Sep; 49(3):463-8. PubMed ID: 2411656
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Trichomonas vaginalis motility by monoclonal antibodies is associated with reduced adherence to HeLa cell monolayers.
Krieger JN; Torian BE; Hom J; Tam MR
Infect Immun; 1990 Jun; 58(6):1634-9. PubMed ID: 2187803
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of polysaccharide and glycoprotein fractions of Trichomonas vaginalis in the serodiagnosis of Trichomonas infections].
Małyszko E; Januszko T; Ustymowicz-Farbiszewska J; Czapska D
Wiad Parazytol; 1991; 37(2):225-33. PubMed ID: 1822039
[TBL] [Abstract][Full Text] [Related]
9. Vaginal antibody of patients with trichomoniasis is to a prominent surface immunogen of Trichomonas vaginalis.
Alderete JF; Newton E; Dennis C; Engbring J; Neale KA
Genitourin Med; 1991 Jun; 67(3):220-5. PubMed ID: 2071124
[TBL] [Abstract][Full Text] [Related]
10. [Research progress on the detection methods of trichomoniasis vaginalis].
Xie H; Zhen CN; Wang YJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Jun; 22(3):179-81. PubMed ID: 15597718
[No Abstract] [Full Text] [Related]
11. Antibodies to Trichomonas vaginalis surface glycolipid.
Bastida-Corcuera FD; Singh BN; Gray GC; Stamper PD; Davuluri M; Schlangen K; Corbeil RR; Corbeil LB
Sex Transm Infect; 2013 Sep; 89(6):467-72. PubMed ID: 23785040
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of epitopes recognized by two monoclonal antibodies that protects mice against Trichomonas vaginalis challenge.
Hernández H; Marcet R; Figueredo M; Garrido N; Sarracent J
Exp Parasitol; 2008 Apr; 118(4):583-6. PubMed ID: 18031741
[TBL] [Abstract][Full Text] [Related]
13. Identification of antigenic proteins in Trichomonas vaginalis.
Lee HY; Hyung S; Lee JW; Kim J; Shin MH; Ryu JS; Park SJ
Korean J Parasitol; 2011 Mar; 49(1):79-83. PubMed ID: 21461274
[TBL] [Abstract][Full Text] [Related]
14. Extensive genetic diversity, unique population structure and evidence of genetic exchange in the sexually transmitted parasite Trichomonas vaginalis.
Conrad MD; Gorman AW; Schillinger JA; Fiori PL; Arroyo R; Malla N; Dubey ML; Gonzalez J; Blank S; Secor WE; Carlton JM
PLoS Negl Trop Dis; 2012; 6(3):e1573. PubMed ID: 22479659
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal-antibody-based enzyme-linked immunosorbent assay for Trichomonas vaginalis.
Lisi PJ; Dondero RS; Kwiatkoski D; Spence MR; Rein MF; Alderete JF
J Clin Microbiol; 1988 Sep; 26(9):1684-6. PubMed ID: 3263386
[TBL] [Abstract][Full Text] [Related]
16. Specific and common antigens of Trichomonas vaginalis detected by monoclonal antibodies.
Torian BE; Connelly RJ; Stephens RS; Stibbs HH
Infect Immun; 1984 Jan; 43(1):270-5. PubMed ID: 6360900
[TBL] [Abstract][Full Text] [Related]
17. Trichomonas vaginalis: evaluating capsid proteins of dsRNA viruses and the dsRNA virus within patients attending a sexually transmitted disease clinic.
Alderete JF; Wendel KA; Rompalo AM; Erbelding EJ; Benchimol M; Chang TH
Exp Parasitol; 2003; 103(1-2):44-50. PubMed ID: 12810045
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of Trichomonas vaginalis infections in the population of Warmińsko-Mazurskie voivodeship (North-Eastern Poland).
Korycińska J; Dzika E; Waśniewski T; Lepczyńska M; Kubiak K
Przegl Epidemiol; 2017; 71(4):547-554. PubMed ID: 29415533
[TBL] [Abstract][Full Text] [Related]
19. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
[TBL] [Abstract][Full Text] [Related]
20. Phenotypes and protein-epitope phenotypic variation among fresh isolates of Trichomonas vaginalis.
Alderete JF; Demĕs P; Gombosová A; Valent M; Yánoska A; Fabusová H; Kasmala L; Garza GE; Metcalfe EC
Infect Immun; 1987 May; 55(5):1037-41. PubMed ID: 2437029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
